Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699

Journal of Bacteriology

Volumn 193, Issue 19, 2011, Pages 5562-5563

  Verma, Mansi ^a   Kaur, Jaspreet ^a   Kumar, Mukesh ^a   Kumari, Kirti ^a   Saxena, Anjali ^a   Anand, Shailly ^a   Nigam, Aeshna ^a   Ravi, Vydianathan ^a   Raghuvanshi, Saurabh ^a   Khurana, Paramjit ^a   Tyagi, Akhilesh K ^a   Khurana, Jitendra P ^a   Lal, Rup ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMYCIN B; RIFAMYCIN DERIVATIVE;

ACTINOBACTERIA; BACTERIAL GENOME; BACTERIAL STRAIN; DRUG INDICATION; GENE SEQUENCE; LEPROSY; MYCOBACTERIOSIS; NOCARDIA MEDITERRANEA; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUBERCULOSIS;

ACTINOMYCETALES; ANTI-BACTERIAL AGENTS; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; RIFAMYCINS;

AMYCOLATOPSIS MEDITERRANEI;

EID: 80053606115     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.05819-11     Document Type: Note

References (16)

1. Admiraal, S. J., C. T. Walsh, and C. Khosla. 2001. The loading module of rifamycin synthetase is an adenylation-thiolation didomain with tolerance for substituted benzoates. Biochemistry 40:6116-6123.
2. August, P. R., et al. 1998. Biosynthesis of the ansamycin antibiotic rifamycin:deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem. Biol. 5:69-79.
3. Bartels, D., et al. 2005. BACCardI-a tool for the validation of genomic assemblies, assisting genome finishing and intergenome comparison. Bioinformatics. 21:853-859.
4. Dickinson, J. M., and D. A. Mitchison. 1987. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria. Tubercle 68:177-182.
5. Doi-Katayama, Y., et al. 2000. Thioesterases and the premature termination of polyketide chain elongation in rifamycin B biosynthesis by Amycolatopsis mediterranei S699. J. Antibiot. (Tokyo) 53:484-495.
6. Lal, R., et al. 1995. Rifamycins: strain improvement program. Crit. Rev. Microbiol. 21:19-30.
7. Lal, R., et al. 2000. Regulation and manipulation of the gene clusters encoding type I PKSs. Trends Biotechnol. 18:264-274.
8. Lechevalier, M. P., H. Prauser, D. P. Labeda, and J. S. Ruan. 1986. Two genera of nocardioform actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov. Int. J. Syst. Bacteriol. 36:29-37.
9. Margalith, P., and G. Beretta. 1960. Rifomycin. XI. Taxonomic study of Streptomyces mediterranei nov. sp. Mycopathol. Mycol. Appl. 13:321-330.
10. Schupp, T., C. Toupet, N. Engel, and S. Goff. 1998. Cloning and sequence analysis of the putative rifamycin polyketide synthase gene cluster from Amycolatopsis mediterranei. FEMS Microbiol. Lett. 159:201-207.
11. Sensi, P., P. Margilith, and M. T. Timbal. 1959. Rifamycin, a new antibiotic. Farmaco. Sci. 14:146-147.
12. Tang, L., Y. J. Yoon, C. Y. Choi, and C. R. Hutchinson. 1998. Characterization of the enzymatic domains in the modular polyketide synthase involved in rifamycin B biosynthesis by Amycolatopsis mediterranei. Gene 216:255-265.
13. Thiemann, J. E., G. Zucco, and G. Pelizza. 1969. A proposal for the transfer of Streptomyces mediterranei Margalith and Beretta 1960 to the genus Nocardia as Nocardia mediterranea (Margalith and Beretta) comb. nov. Arch. Mikrobiol. 67:147-155.
14. Woodley, C. L., and J. O. Kilburn. 1982. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiropiperidyl rifamycin. Am. Rev. Respir. Dis. 126:586-587.
15. Xu, J., E. Wan, C. J. Kim, H. G. Floss, and T. Mahmud. 2005. Identification of tailoring genes involved in the modification of the polyketide backbone of rifamycin B by Amycolatopsis mediterranei S699. Microbiology 151:2515-2528.
16. Zhao, W., et al. 2010. Complete genome sequence of the rifamycin SVproducing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell Res. 20:1096-1108.